Brief: Neximmune Reports First Quarter 2023 Financial Results And Provides Business Updates
15/05/2023 21:31
Neximmune Inc NEXI.O :
* NEXIMMUNE REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATES
* NEXIMMUNE - CASH AND CASH EQUIVALENTS AS OF MARCH 31 WERE
$22.3
MILLION
* NEXIMMUNE - EXPECTS EXISTING CASH, CASH EQUIVALENTS WILL
ENABLE
CO TO FUND OPERATING AND CAPITAL EXPENDITURE REQUIREMENTS INTO
Q4 OF 2023
* NEXIMMUNE INC - QTRLY NET LOSS PER SHARE OF $0.37
Source text for Eikon: ID:nGNXZCXLT
Further company coverage: NEXI.O
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting